NICE (UK National Institute for Clinical Excellence) recommends press-and-breathe asthma inhalers
This article was originally published in Clinica
Press-and-breathe pressurised metered-dose inhalers, used with the appropriate spacer, have become the technology of choice in treating 5-15 year-old chronic asthmatics under the UK NHS, after the National Institute for Clinical Excellence (NICE) last week recommended its use.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.